RenovoRx Market Capitalization from 2010 to 2025
| RNXT Stock | USD 0.97 0.02 2.02% |
Check RenovoRx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among RenovoRx's main balance sheet or income statement drivers, such as Net Interest Income of 134 K, Interest Income of 64.3 K or Depreciation And Amortization of 5.1 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. RenovoRx financial statements analysis is a perfect complement when working with RenovoRx Valuation or Volatility modules.
RenovoRx | Market Capitalization |
Latest RenovoRx's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of RenovoRx over the last few years. It is RenovoRx's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in RenovoRx's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 34.49 M | 10 Years Trend |
|
Market Cap |
| Timeline |
RenovoRx Market Capitalization Regression Statistics
| Arithmetic Mean | 53,372,584 | |
| Geometric Mean | 50,303,003 | |
| Coefficient Of Variation | 29.61 | |
| Mean Deviation | 13,079,775 | |
| Median | 62,885,147 | |
| Standard Deviation | 15,805,504 | |
| Sample Variance | 249.8T | |
| Range | 41.6M | |
| R-Value | (0.73) | |
| Mean Square Error | 125.1T | |
| R-Squared | 0.53 | |
| Significance | 0 | |
| Slope | (2,422,543) | |
| Total Sum of Squares | 3747.2T |
RenovoRx Market Capitalization History
About RenovoRx Financial Statements
RenovoRx shareholders use historical fundamental indicators, such as Market Capitalization, to determine how well the company is positioned to perform in the future. Although RenovoRx investors may analyze each financial statement separately, they are all interrelated. The changes in RenovoRx's assets and liabilities, for example, are also reflected in the revenues and expenses on on RenovoRx's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California. Renovorx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 10 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RenovoRx Stock Analysis
When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.